ViroPharma Announces the First EU Market to Launch Plenadren

ViroPharma Announces The First EU Market To Launch Plenadren
Filed under: adolescent dual diagnosis

Plenadren is taken orally as a single dose in the morning and has been designed to provide a dual release pattern of hydrocortisone.[1] The outer coating provides a high concentration of cortisol in the morning, meeting the body's requirements.
{Source}